Advocacy Up Close: Dr. Gary Bryant Discusses the Role & Benefits of RheumPAC
RheumPAC, the ACR’s political action committee (PAC), is tasked with fundraising, vetting legislators, participating in Capitol Hill visits and developing important relationships for the College. During my interview with Gary Bryant, MD, the ACR’s inaugural RheumPAC chair, he shared his thoughts on the role of rheumatology advocacy in advancing clinical practice, research and education. ACR@Work: Have... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - April 18, 2019 Category: Rheumatology Authors: Maura Iversen, BSc, PT, DPT, SD, MPH Tags: Legislation & Advocacy Rheuminations Gary Bryant political action committee (PAC) rheumatology advocacy RheumPAC Source Type: research

Dr. Shervin Assassi: New Chair of the ACR Committee on Journal Publications
Shervin Assassi, MD, MS, was the child of two physicians. His mother practiced obstetrics, and his father was a trauma surgeon. It gave him an appreciation for the hard work that goes into medicine and a fascination for joints. He developed an interest in immunology while in medical school. “It was natural for me to... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - April 18, 2019 Category: Rheumatology Authors: Kelly Tyrrell Tags: Profiles ACR Committee on Journal Publications Shervin Assassi Source Type: research

More Data for Treat to Target: Post-hoc analysis of large RA clinical trials supports treat-to-target recommendations
A post-hoc analysis of data from two large clinical trials supports treat-to-target recommendations for patients with rheumatoid arthritis. The research found baseline disease activity was the strongest predictor of a patient’s insufficient response to initial therapy at six months... (Source: The Rheumatologist)
Source: The Rheumatologist - April 17, 2019 Category: Rheumatology Authors: Gretchen Henkel Tags: Conditions Rheumatoid Arthritis biologic therapies recommendations Rheumatoid Arthritis (RA) Treat-to-Target Source Type: research

First-Year Medical Residents Spend Little Time on Patient Care
(Reuters Health)—Over a typical 24-hour shift, first year residents training in internal medicine spend just three hours on direct patient care and only 1.8 hours on education, a U.S. study suggests. Most of their time—an average of 15.9 hours out of every 24-hour shift—is consumed instead by “indirect patient care,” primarily involving interactions with medical... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - April 17, 2019 Category: Rheumatology Authors: Lisa Rapaport Tags: Education & Training electronic health record graduate medical education medical students patient care Source Type: research

Clusters of Autoimmune Liver Disease Suggest Environmental Trigger
NEW YORK (Reuters Health)—A large population-based study from the U.K. provides more evidence that some autoimmune liver diseases may be triggered by exposure to something in the environment. The study found a significant clustering of cases of primary biliary cholangitis (PBC), autoimmune hepatitis (AIH) and primary sclerosing cholangitis (PSC) in well-defined regions of north-east England... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - April 17, 2019 Category: Rheumatology Authors: Reuters Staff Tags: Conditions autoimmune hepatitis environment environmental factor liver primary sclerosing cholangitis Source Type: research

Coding Corner Question: How to Bill a Rituximab Infusion Visit?
A 66-year-old female patient returns for a second infusion of rituximab for her diagnosis of rheumatoid arthritis in multiple sites. She is rheumatoid factor positive. She says the pain in her knees, elbows and neck has slightly improved. She rates the severity of her pain at a 7 on a 10-point scale, which is an... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - April 16, 2019 Category: Rheumatology Authors: From the College Tags: Billing/Coding From the College Rheumatoid Arthritis Infusion rituximab Source Type: research

Coding Corner Answer: How to Bill a Rituximab Infusion Visit?
Take the challenge. CPT Codes: 96413, 96415 x 3, J9312 x 5, 96365, J2930 Diagnoses: M05.79 Coding Rationale As of Jan. 1, 2019, the Healthcare Common Procedure Coding System (HCPCS) code for rituximab was changed from J9310 rituximab 100 mg, to the new HCPCS code J9312 (injection, rituximab, 100 mg). According to a Verywell Health... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - April 16, 2019 Category: Rheumatology Authors: From the College Tags: Billing/Coding From the College Rheumatoid Arthritis Infusion rituximab Source Type: research

Time Plays an Important Role in Selecting the Best Services Billing Code
The evaluation and management (E/M) code set in the American Medical Association’s Current Procedural Terminology (CPT) book lists descriptors, as well as typical times for patient visits. These times are averages of how long it takes a physician to complete all components of a visit at each level. Because the specific times identified in the... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - April 16, 2019 Category: Rheumatology Authors: From the College Tags: Billing/Coding From the College Practice Management Current Procedural Terminology (CPT) codes evaluation and management (E/M) codes Source Type: research

New ACR Treasurer Selected
The ACR welcomes David Karp, MD, PhD, UT Southwestern, Dallas, to serve as ACR treasurer for 2019. As a returning member of the Executive Committee, Dr. Karp brings a breadth of ACR volunteer experience. His past roles have included serving as the Rheumatology Research Foundation president, as well as an ACR board member. (Source: The Rheumatologist)
Source: The Rheumatologist - April 16, 2019 Category: Rheumatology Authors: From the College Tags: From the College Dr. David Karp Leader Source Type: research

Why Fellows Should Care about ACR Advocacy
As a physician, I am an advocate. I am an advocate for my patients individually and collectively, and I am an advocate for my field: pediatric rheumatology. My own experiences as a patient drive me to integrate my patients’ perspectives into my medical decision making, and although my academic training has prepared me to best... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - April 16, 2019 Category: Rheumatology Authors: From the College Tags: From the College Legislation & Advocacy RheumPAC Source Type: research

New Research Foundation Award Supports the Future of Rheumatology
The workforce shortage in rheumatology is a critical issue the Rheumatology Research Foundation is tackling. The number of patients with rheumatic disease is growing exponentially, and that means more health professionals and innovative approaches are needed to ensure rheumatology practices are set up to offer the best care. In 2018, the ARP released a core... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - April 16, 2019 Category: Rheumatology Authors: From the College Tags: From the College Workforce Rheumatology Research Foundation workforce shortage Source Type: research

Dr. Brit Adler Treks Across Glaciers & Forages for Mushrooms
In November 2017, Brit Adler, MD, an instructor in the Division of Rheumatology at Johns Hopkins University, Baltimore, was traveling across a glacier in the Cordillera Blanca mountain range in Peru. At nearly 15,000 feet high, the hikers in the caravan were secured to each other by ropes secured to harnesses. At that altitude, no... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - April 16, 2019 Category: Rheumatology Authors: Carol Patton Tags: Profiles Rheum After 5 Dr. Brit Adler Source Type: research

U.S. Supreme Court Rejects Allergan Bid to Use Tribe to Shield Drug Patents
WASHINGTON (Reuters)—The U.S. Supreme Court has cast aside pharmaceutical company Allergan Plc.’s unorthodox bid to shield patents from a federal administrative court’s review by transferring them to a Native American tribe. The justices left in place a lower court ruling upholding the authority of a U.S. Patent and Trademark Office tribunal to decide the validity... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - April 16, 2019 Category: Rheumatology Authors: Natasha Yetman Tags: Drug Updates Allergan Plc tribal patent deal Allergan Plc. Legal Native American tribe New York Saint Regis Mohawk Tribe Restasis Source Type: research

Patient Safety at Home: What Are Our Legal & Ethical Responsibilities?
A 60-year-old woman with a six-month history of retroperitoneal fibrosis transfers her care to you. She initially presented with severe bilateral flank pain radiating to the abdomen and chest. A computerized tomography (CT) angiogram of the abdomen demonstrated an infrarenal abdominal aortic aneurysm surrounded by a thick inflammatory rind entangling the left renal vein and... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - April 15, 2019 Category: Rheumatology Authors: Sarah F. Keller, MD, & Marcy B. Bolster, MD Tags: Ethics Legal abuse patient safety reporting Source Type: research

Experts Offer Management Tips, from Contracts to Credentials to Audits
CHICAGO—Medical practice consultant Owen Dahl, MBA, LFACHE, CHBC, looked out at the rheumatology practice managers and physicians, sitting around tables with white tablecloths, and asked what seemed like a simple question: “How many of you have a strategic plan?” he asked. A single hand was raised. “One? How do you know where to go tomorrow... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - April 15, 2019 Category: Rheumatology Authors: Thomas R. Collins Tags: Practice Management 2018 ACR/ARHP Annual Meeting Audits Compliance Contract credentialing Source Type: research

Tips for Interdisciplinary Pain Management in Older Patients
CHICAGO—Rheumatology healthcare providers should embrace collaborative approaches to manage chronic musculoskeletal pain in older adult patients, including models of care that involve multiple providers, patients and their caregivers. That was the message delivered by two speakers in the Interdisciplinary Management of Chronic Musculo­skeletal Pain in Older Adults session at the 2018 ACR/ARHP Annual Meeting. “As... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - April 15, 2019 Category: Rheumatology Authors: Susan Bernstein Tags: Analgesics Conditions 2018 ACR/ARHP Annual Meeting biopsychosocial collaboration Exercise interdisciplinary Pain Management stepped care Source Type: research

Japan Approves Risankizumab for Psoriasis & Psoriatic Arthritis
Japan has approved risankizumab for treating plaque psoriasis, generalized pustular psoriasis, erythrodermic psoriasis and psoriatic arthritis in adults... (Source: The Rheumatologist)
Source: The Rheumatologist - April 15, 2019 Category: Rheumatology Authors: Michele B. Kaufman, PharmD, BCGP Tags: Biologics & Biosimilars Drug Updates Japan Psoriasis psoriatic arthritis risankizumab Source Type: research

Dietary Calcium Intake Not Associated with Bone Loss
Postmenopausal women are often told to consume more than 1,500 mg of calcium daily to reach neutral bone balance. But new research suggests this recommendation should be revised, finding no connection between dietary calcium intake and postmenopausal bone loss... (Source: The Rheumatologist)
Source: The Rheumatologist - April 15, 2019 Category: Rheumatology Authors: Lara C. Pullen, PhD Tags: Conditions bone loss bone mineral density (BMD) calcium Diet fracture Osteoporosis Source Type: research

Metrics in Rheumatology: Focus on Harold E. (Hal) Paulus, MD
We have just learned that Dr. Hal Paulus passed away on April 5, 2019. We are reposting this story today in his memory and will share additional information as we learn it. (Source: The Rheumatologist)
Source: The Rheumatologist - April 11, 2019 Category: Rheumatology Authors: Gretchen Henkel Tags: Conditions Profiles Rheumatoid Arthritis Career Patients Paulus RA Research Training Source Type: research

Mirikizumab Promising for Plaque Psoriasis
During a 16-week study, patients with plaque psoriasis taking mirikizumab experienced higher response rates and skin clearance compared with placebo... (Source: The Rheumatologist)
Source: The Rheumatologist - April 10, 2019 Category: Rheumatology Authors: Michele B. Kaufman, PharmD, BCGP Tags: Biologics & Biosimilars Drug Updates mirikizumab plaque psoriasis skin Source Type: research

For Psoriasis, Ustekinumab & TNF Inhibitors Show Similar Cardiac Safety
NEW YORK (Reuters Health)—In patients with psoriatic disease, the incidence of atrial fibrillation and major adverse cardiovascular events does not differ between treatment with ustekinumab and TNF inhibitors, according to a large observational study. “Given a high cardiovascular risk among patients with psoriasis and psoriatic arthritis,” Seoyoung C. Kim, MD, ScD, MSCE, told Reuters Health... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - April 9, 2019 Category: Rheumatology Authors: David Douglas Tags: Conditions cardiovascular cardiovascular event Psoratic Arthritis Psoriasis Safety TNF inhibitor ustekinumab Source Type: research

Pregnancy Outcomes in Women with Idiopathic Inflammatory Myositis
New data from India suggest women with idiopathic inflammatory myositis are at increased risk of poor fetal outcomes and spontaneous abortions. In the study, researchers found these women had worse obstetric outcomes and increased risk of fetal complications... (Source: The Rheumatologist)
Source: The Rheumatologist - April 8, 2019 Category: Rheumatology Authors: Lara C. Pullen, PhD Tags: Conditions birth idiopathic inflammatory myositis Outcomes pregnancy pregnant women Source Type: research

State Step Therapy Laws: Not All Are Created Equal
Step therapy reform has been a hot topic and major focus of the ACR’s advocacy activity in states this legislative session. Washington, Oregon, Wisconsin and Florida are all considering step therapy bills that stand good chance of passing this legislative year. Virginia and Georgia have already passed step therapy laws. When these two new laws... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - April 8, 2019 Category: Rheumatology Authors: From the College Tags: Legislation & Advocacy step therapy step therapy reform legislation Source Type: research

Value for Service: ACR Update on RUC & CPT Activities
The American Medical Association (AMA) Relative Value Update Committee (RUC) and Current Procedural Terminology (CPT) meet three times a year to keep the CPT code set up to date and review resource costs for physicians. The two-step meetings of the CPT Editorial Panel and the RUC allow physicians to provide direct input to the Centers... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - April 4, 2019 Category: Rheumatology Authors: From the College Tags: Billing/Coding Practice Management E/M codes evaluation and management codes Source Type: research

Health Canada Approves Adalimumab for Chronic Non-Infectious Anterior Uveitis in Pediatric Patients
Health Canada has approved adalimumab for treating chronic non-infectious anterior uveitis in patients 2 years and older... (Source: The Rheumatologist)
Source: The Rheumatologist - April 3, 2019 Category: Rheumatology Authors: Michele B. Kaufman, PharmD, BCGP Tags: Biologics & Biosimilars Drug Updates adalimumab non-infectious anterior uveitis Pediatric Source Type: research

In It Together: Peer-Support Programs Help Physicians After Stressful Events
A formal peer-support program for medical providers affected by stress and trauma is gradually becoming a cultural norm for rheumatologists and other physicians at Johns Hopkins University... (Source: The Rheumatologist)
Source: The Rheumatologist - April 3, 2019 Category: Rheumatology Authors: Carina Stanton Tags: Practice Management Source Type: research

Closed Case? ACR Fights CMS Proposed Changes for E/M Reimbursement
When the Centers for Medicare and Medicaid Services (CMS) proposed coding and documentation changes to consolidate evaluation and management (E/M) services last fall, the ACR was among many specialist societies actively involved in advocating against the proposed ruling. The changes to E/M coding were part of a larger initiative to reduce the documentation burden on... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - April 3, 2019 Category: Rheumatology Authors: Cindy Devone-Pacheco Tags: Billing/Coding Legislation & Advocacy Practice Management coding and documentation changes Cognitive Care Alliance (CCA) Colin C. Edgerton consolidate E/M services E/M Coding Timothy J. Laing U.S. Centers for Medicare and Medicaid Servic Source Type: research

Advocacy Begins at Home
As the frustration with changes in healthcare grows, and after speaking with the vociferous advocates who are part of the ACR, you have decided that you need to become involved in advocacy for your patients, your practice and your profession. Welcome to the fold. How to Help from Home Many people indicate they aren’t more... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - April 3, 2019 Category: Rheumatology Authors: Chris Morris, MD Tags: Legislation & Advocacy advocate from home Legislative Action Center RheumPAC Source Type: research

Tracking Bone Deterioration in Patients with Ankylosing Spondylitis
Trabecular bone score and high-resolution peripheral quantitative computed tomography may be effective for evaluating bone impairment in patients ankylosing spondylitis (AS). Rheumatologists may be able to use these methods, complementary to dual-energy X-ray absorptiometry, to identify bone quality deterioration in AS patients. (Source: The Rheumatologist)
Source: The Rheumatologist - April 2, 2019 Category: Rheumatology Authors: Lara C. Pullen, PhD Tags: Conditions Spondyloarthritis Ankylosing spondylitis Ankylosing spondylitis (AS) bone density bone mineral density (BMD) spine Source Type: research

Has Rheumatology Become a More Attractive Career?
Rheumatology has historically been a common career choice than other internal medicine subspecialties, but that may be changing... (Source: The Rheumatologist)
Source: The Rheumatologist - April 2, 2019 Category: Rheumatology Authors: Arthritis Care & Research Tags: Professional Topics Arthritis Care & Research Career fellowship fellowship training slots rheumatology Source Type: research

Build Your Practice with Patient-Centered Strategies
Ever wonder why some rheumatologists are more successful at starting or building a private practice than their peers? More than likely, their success is due in part to the patient-centered strategies embedded in their practices’ cultures. Although the ACR predicts a nationwide shortage of 2,500 rheumatologists within the next decade, many patients can still pick... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - April 2, 2019 Category: Rheumatology Authors: Carol Patton Tags: Patient Perspective Practice Management Quality Assurance/Improvement patient care patient satisfaction Private practice Source Type: research

Myocardial Inflammation Associated with RA Disease Activity
Introduction: Heart failure, a key contributor to cardiovascular disease (CVD) morbidity and mortality, is associated with fewer symptoms and higher (preserved) ejection fraction, but higher mortality rates, in rheumatoid arthritis (RA) patients than among those in the general population. In the general population, higher levels of circulating proinflammatory cytokines, such as tumor necrosis factor (TNF)... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - March 28, 2019 Category: Rheumatology Authors: Arthritis & Rheumatology Tags: Conditions Rheumatoid Arthritis Arthritis & Rheumatology cardiovascular Cardiovascular disease heart Source Type: research

Carpal Tunnel Syndrome of Pregnancy May Persist Long After Delivery
NEW YORK (Reuters Health)—About 15% of women who develop carpal tunnel syndrome (CTS) while pregnant will suffer persistent and worsening symptoms long after delivery, a new study suggests. “Conventional medical wisdom has been that gestational carpal tunnel syndrome simply goes away after pregnancy, and for many women this is true. However, in our practice this... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - March 27, 2019 Category: Rheumatology Authors: Megan Brooks Tags: Conditions Carpal Tunnel Syndrome gestational CTS pregnancy pregnancy complications pregnant women Source Type: research

Women Diagnosed Years Later than Men for Same Diseases
(Reuters Health)—For a wide range of diseases, diagnosis comes later in life for women than for men, according to a large Danish study. Researchers don’t know whether the later diagnoses are due to genetics, the environment, possible biases in the healthcare system—or some combination of reasons. The study of health data from 6.9 million Danish... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - March 27, 2019 Category: Rheumatology Authors: Tamara Mathias Tags: Conditions Diagnosis Women Source Type: research

SM04690 Promising for Knee OA
SM04690, an intra-articular injection for knee OA, will soon enter phase 3 trials to assess its effects on pain, joint function and disease... (Source: The Rheumatologist)
Source: The Rheumatologist - March 27, 2019 Category: Rheumatology Authors: Michele B. Kaufman, PharmD, BCGP Tags: Drug Updates disease-modifying osteoarthritis drug (DMOAD) joint injection knee Knee Osteoarthritis (OA) SM04690 Source Type: research

Kentucky Launches Probe into Drug Overcharges by Pharmacy Benefit Managers
(Reuters)—Kentucky Attorney General Andy Beshear said on Thursday he had launched an investigation into allegations that pharmacy benefit managers (PBMs) had overcharged state health insurance programs for drugs and discriminated against independent pharmacies. The investigation comes against the backdrop of widespread criticism of rising costs of prescription medicines in the United States, with PBMs, middlemen... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - March 26, 2019 Category: Rheumatology Authors: Reuters Staff Tags: Legal Pharma Co. News Kentucky PBM probe pharmacy benefit managers (PBMs) rising U.S. drug costs Source Type: research

Galectin-3 May Be a Biomarker for Cardiovascular Disease in RA
Galectin-3 may have potential as a biomarker for the early onset of cardiovascular disease in RA patients, potentially enabling early intervention and deferring the cardiovascular risks associated with RA... (Source: The Rheumatologist)
Source: The Rheumatologist - March 25, 2019 Category: Rheumatology Authors: Carina Stanton Tags: Conditions Rheumatoid Arthritis cardiovascular Cardiovascular disease galectin‐3 Rheumatoid Arthritis (RA) risk Source Type: research

MRI-Guided Therapy Offers No Improvement Over Conventional Treat to Target for RA
New research does not support the use of a magnetic resonance imaging (MRI)-guided strategy for treating RA patients. The study found that among RA patients in remission, an MRI-guided treat-to-target strategy compared with a conventional treat-to-target strategy did not result in improved disease activity remission rates or reduced radiographic progression... (Source: The Rheumatologist)
Source: The Rheumatologist - March 25, 2019 Category: Rheumatology Authors: Lara C. Pullen, PhD Tags: Conditions Rheumatoid Arthritis Magnetic resonance imaging (MRI) Rheumatoid Arthritis (RA) Source Type: research

Ohio Accuses UnitedHealth ’s OptumRx of Drug Overcharges
(Reuters)—Ohio’s attorney general on Monday said he had filed a lawsuit against UnitedHealth Group Inc’s OptumRx unit, saying the pharmacy benefit manager had overcharged the state nearly $16 million for prescription drugs. Ohio Attorney General Dave Yost’s lawsuit followed a probe into the extent pharmacy benefit managers (PBMs) like OptumRx had engaged in pricing practices... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - March 23, 2019 Category: Rheumatology Authors: Nate Raymond Tags: Legal Professional Topics lawsuit Ohio pharmacy benefit managers pharmacy benefit managers (PBMs) Source Type: research

Knee Replacement in Younger Patients Has Higher Complication Rate
NEW YORK (Reuters Health)—Total knee replacement (TKA) is increasingly being performed in younger patients, and new research suggests that these patients have a higher risk for complications than older patients. “The number of knee replacements we are doing in younger and younger patients keeps increasing every year and we need to let these patients know... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - March 23, 2019 Category: Rheumatology Authors: Megan Brooks Tags: Conditions Osteoarthritis knee total knee arthroplasty total knee replacement Source Type: research

Joining Forces to Advance Pediatric Rheumatology Care
Pediatric rheumatologists are in high demand. In fact, a shortage of pediatric rheumatologists requires more than half of all U.S. children with rheumatic diseases seek care with adult rheumatologists, and this shortage is projected to increase. For the past decade, the ACR’s Special Committee on Pediatric Rheumatology has worked to change this by bringing together... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - March 21, 2019 Category: Rheumatology Authors: Carina Stanton Tags: Profiles ACR’s Pediatric Rheumatology Special Committee ACR/CARRA Mentoring Interest Group for Pediatric Rheumatologists (AMIGO) Jay Mehta Pediatric Rheumatology Residency Program Source Type: research

Bringing a Frontline Perspective to Insurance Advocacy
Early in his career as a resident at Washington University in St. Louis, Mo., Christopher Phillips, MD, felt a connection to his patients battling rheumatic diseases. Today, Dr. Phillips balances time with his solo private practice in Paducah, Ky., to help rheumatologists fight insurance battles for their patients in his role as chair of the... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - March 21, 2019 Category: Rheumatology Authors: Carina Stanton Tags: Profiles ACR Insurance Subcommittee (ISC) Christopher Phillips Source Type: research

ACR Addresses Workforce Challenges at the State Level
Like many states in recent years, Georgia has struggled to provide patients with adequate access to rheumatologists and other cognitive specialists, with Georgia averaging 74,713 people per rheumatologist. Of equal concern, 31% of Georgia’s rheumatologists are approaching retirement age. During the current legislative session, the ACR has stepped up with a proposal to alleviate some... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - March 21, 2019 Category: Rheumatology Authors: From the College Tags: From the College Legislation & Advocacy Georgia state workforce legislation H.B. 442 loan forgiveness program Source Type: research

FDA Approves Guselkumab Injector
The FDA has approved a single-press, self-injection device for a 100-mg dose of guselkumab for adults with moderate to severe plaque psoriasis... (Source: The Rheumatologist)
Source: The Rheumatologist - March 20, 2019 Category: Rheumatology Authors: Michele B. Kaufman, PharmD, BCGP Tags: Biologics & Biosimilars Drug Updates Source Type: research

Osteoporosis Experts Discuss Bisphosphonates, Chronic Kidney Disease
CHICAGO—The osteoporosis session at the 2018 ACR/ARHP Annual Meeting opened with a discussion by Kenneth Saag, MD, MSc, professor of medicine at the University of Alabama, Birmingham, in which he highlighted adverse events associated with osteoporosis medications. Dr. Saag began his presentation by emphasizing that, above all, the audience should keep in mind that the... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - March 19, 2019 Category: Rheumatology Authors: Lara C. Pullen, PhD Tags: Conditions Meeting Reports 2018 ACR/ARHP Annual Meeting Association of Rheumatology Professionals (ARP) Bisphosphonate chronic kidney disease Source Type: research

Insights on the Diagnosis & Treatment of Low Back & Hip Pain
CHICAGO—Two experts presented insights on the diagnosis and treatment of low back and hip pain, including a refresher course on the mechanical structures involved, in Anatomy in a Day: Demystifying Low Back Pain and Lateral Hip Pain: New Patho-Anatomical Perspectives, a session at the 2018 ACR/ARHP Annual Meeting. Low Back Pain Avoid using such terms... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - March 19, 2019 Category: Rheumatology Authors: Susan Bernstein Tags: Conditions Meeting Reports 2018 ACR/ARHP Annual Meeting hip pain low back pain Ultrasound Source Type: research

The Latest on Vaccinations, Leprosy & Lyme Disease
CHICAGO—Keith Winthrop, MD, MPH, professor of public health and preventive medicine at the Oregon Health & Science University School of Medicine, Portland, Ore., began the vaccination session at the 2018 ACR/ARHP Annual Meeting with a review of vaccination timing and targets. He presented a clinically relevant snapshot of the vaccines rheumatologists should consider and emphasized... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - March 19, 2019 Category: Rheumatology Authors: Lara C. Pullen, PhD Tags: Conditions Meeting Reports 2018 ACR/ARHP Annual Meeting leprosy Lyme Disease vaccination Source Type: research

Research Is Advancing Our Understanding of Gout & Hyperuricemia
CHICAGO—The Gout and Hyperuricemia scientific session at the 2018 ACR/ARHP Annual Meeting opened with a talk by Tony R. Merriman, PhD, a research professor at the University of Otago, New Zealand. His talk focused on molecular epidemiology, with an emphasis on the interactions between genes and environmental exposures, and their contributions to gout. Dr. Merriman... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - March 19, 2019 Category: Rheumatology Authors: Lara C. Pullen, PhD Tags: Conditions Crystal Arthritis Meeting Reports 2018 ACR/ARHP Annual Meeting Gout Human Functional Genomics Projects hyperuricemia Source Type: research

Disease Mimicry: Genetic Diseases Can Produce Rheumatic Symptoms
CHICAGO—The 2018 ACR/ARHP Annual Meeting session on genetic mimics of rheumatic disease began with a description of a patient who presented with the symptoms of childhood-onset lupus but instead had a well-defined genetic disease: lysinuric protein intolerance (LPI). Lindsay Burrage, MD, PhD, assistant professor of molecular and human genetics at Baylor College of Medicine, Houston,... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - March 19, 2019 Category: Rheumatology Authors: Lara C. Pullen, PhD Tags: Conditions Meeting Reports 2018 ACR/ARHP Annual Meeting Fabry disease genetic disease lysinuric protein intolerance mimics Source Type: research

Disaster Preparedness in Rheumatology —Are You Ready?
CHICAGO—“You never know when things might happen,” began Kamala M. Nola PharmD, MS, vice chair and professor in the Department of Pharmacy Practice at Lipscomb College of Pharmacy, Nashville, at the 2018 ACR/ARHP Annual Meeting. Dr. Nola explained that on May 1, 2010, the Arthritis Foundation Arthritis Walk held on her university’s campus was moved... [Read More] (Source: The Rheumatologist)
Source: The Rheumatologist - March 19, 2019 Category: Rheumatology Authors: Lara C. Pullen, PhD Tags: Facility Meeting Reports Professional Topics 2018 ACR/ARHP Annual Meeting Disaster preparation Natural disaster Source Type: research